Molecular docking of medicinal plants: Towards metabolic disease management

The rising global burden of metabolic disease, together with the high cost and limited accessibility of conventional antidiabetic therapeutics in sub-Saharan Africa, has renewed interest in agriculturally cultivated medicinal plants as sustainable sources of bioactive phytochemicals with well-documented ethnopharmacological relevance. This study aimed to identify and prioritize phytochemicals with therapeutic potential against validated metabolic disease targets through an integrated computational drug discovery workflow. 14 bioactive phytochemicals from six agricultural medicinal plants- Moringa oleifera, Vernonia amygdalina, Azadirachta indica, Curcuma longa, Hibiscus sabdariffa, and Zingiber officinale were retrieved from PubChem and docked against five protein targets implicated in type 2 diabetes mellitus (T2DM) and metabolic syndrome: α-glucosidase (PDB: 3W37), dipeptidyl peptidase-4 (DPP-4; PDB: 2I78), peroxisome proliferator-activated receptor gamma (PPARγ; PDB: 2PRG), α-amylase (PDB: 1B2Y), and glucose transporter type 2 (GLUT2; PDB: 5EQG). Docking was performed in AutoDock Vina via PyRx 0.8, ADMET properties were predicted using SwissADME and ADMETlab 3.0, and a random forest classifier trained on ChEMBL 33 bioactivity data was used for artificial intelligence-assisted lead prioritization. Nimbolide from A. indica showed the strongest binding affinity, docking against PPARγ at - 8.4 kcal/mol, while hibiscetin from H. sabdariffa bound GLUT2 at - 7.6 kcal/mol. Quercetin and 6-gingerol inhibited α-glucosidase more strongly than the reference drug acarbose (- 6.5 kcal/mol). All priority leads satisfied Lipinski’s Rule of Five and displayed favorable, low-risk ADMET profiles. The integration of ethnopharmacological plant selection, molecular docking, ADMET prediction, and AI-assisted prioritization identified nimbolide, hibiscetin, quercetin, and curcumin as promising, sustainable phytochemical leads for metabolic disease management in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-08-20
DOI
https://doi.org/10.5281/zenodo.22034978
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular docking of medicinal plants: Towards metabolic disease management

Mediterranean Journal of Medical Research
Zenodo (CERN European Organization for Nuclear Research)
Natural Antidiabetic Agents Studies
article

Molecular docking of medicinal plants: Towards metabolic disease management

Mediterranean Journal of Medical Research
article en

Abstract

The rising global burden of metabolic disease, together with the high cost and limited accessibility of conventional antidiabetic therapeutics in sub-Saharan Africa, has renewed interest in agriculturally cultivated medicinal plants as sustainable sources of bioactive phytochemicals with well-documented ethnopharmacological relevance. This study aimed to identify and prioritize phytochemicals with therapeutic potential against validated metabolic disease targets through an integrated computational drug discovery workflow. 14 bioactive phytochemicals from six agricultural medicinal plants- Moringa oleifera, Vernonia amygdalina, Azadirachta indica, Curcuma longa, Hibiscus sabdariffa, and Zingiber officinale were retrieved from PubChem and docked against five protein targets implicated in type 2 diabetes mellitus (T2DM) and metabolic syndrome: α-glucosidase (PDB: 3W37), dipeptidyl peptidase-4 (DPP-4; PDB: 2I78), peroxisome proliferator-activated receptor gamma (PPARγ; PDB: 2PRG), α-amylase (PDB: 1B2Y), and glucose transporter type 2 (GLUT2; PDB: 5EQG). Docking was performed in AutoDock Vina via PyRx 0.8, ADMET properties were predicted using SwissADME and ADMETlab 3.0, and a random forest classifier trained on ChEMBL 33 bioactivity data was used for artificial intelligence-assisted lead prioritization. Nimbolide from A. indica showed the strongest binding affinity, docking against PPARγ at - 8.4 kcal/mol, while hibiscetin from H. sabdariffa bound GLUT2 at - 7.6 kcal/mol. Quercetin and 6-gingerol inhibited α-glucosidase more strongly than the reference drug acarbose (- 6.5 kcal/mol). All priority leads satisfied Lipinski’s Rule of Five and displayed favorable, low-risk ADMET profiles. The integration of ethnopharmacological plant selection, molecular docking, ADMET prediction, and AI-assisted prioritization identified nimbolide, hibiscetin, quercetin, and curcumin as promising, sustainable phytochemical leads for metabolic disease management in resource-limited settings.

Zenodo (CERN European Organization for Nuclear Research)
American Society of Consultant Pharmacists (US)
Zero hunger
Openalex Percentile: Top 9%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.